Thomas Strasser

Thomas Strasser

Auto-generated profile, based on publicly available information

Thomas Strasser

Department of Orthopedic Surgery, Riverside University Health System, Moreno Valley, California

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
JAJ. Michael Anderson
J. Michael Anderson
CHConner Howard
Conner Howard
JSJordan Staggs
Jordan Staggs
RSRobert Steele
Robert Steele
TSThomas Strasser
Thomas Strasser
JCJake X. Checketts
Jake X. Checketts

1 November 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MKMichael W. Kortz
Michael W. Kortz
EMEdwin McCray
Edwin McCray
TSThomas Strasser
Thomas Strasser
GKGretchen Koller
Gretchen Koller
NSNathan A. Shlobin
Nathan A. Shlobin
NDNader S. Dahdaleh
Nader S. Dahdaleh

1 February 2018 in Journal of Archaeological Science: Reports
Verified
Journal Article
Closed access
TCTristan Carter
Tristan Carter
TSThomas F. Strasser
Thomas F. Strasser
EPEleni Panagopoulou
Eleni Panagopoulou
KCKathryn Campeau
Kathryn Campeau
DMDanica D. Mihailović
Danica D. Mihailović

29 May 2026 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
TSThomas Strasser
Thomas Strasser
CBChristopher Baker
Christopher Baker
JCJenna Cheminant
Jenna Cheminant
BHBlake Han
Blake Han
SCSallie Canumay
Sallie Canumay
JSJohn Schlechter
John Schlechter
Background: The utilization of artificial intelligence (AI), such as machine learning, in health care has risen exponentially, underscoring the necessity of transparency and traceability in the reporting of AI in randomized controlled trials (RCTs) that involve AI. In 2020, a CONSORT (Consolidated Standards of Reporting Trials) AI extension was published that included 14 additional items that should be reported when AI is used in RCTs. This study aimed to evaluate compliance with these additional guidelines. Methods: A systematic approach was used to identify all RCTs in orthopaedics that involved AI since the extension was published. Three databases were searched (PubMed, Embase, Cochrane) using the search terms ([orthopaedic] OR [orthopedic]) AND ([artificial intelligence] OR [AI] OR [machine learning] OR [deep learning]). Results: One hundred and seventy-four articles were identified, and 11 articles satisfied the inclusion and exclusion criteria and were assessed for compliance. The average number of CONSORT AI-extension items met per study was 11.4 ± 1.6 (81.2% ± 12.1%). Eight items (1a [i], 1b [ii], 2a [i], 4a [i], 5 [ii], 5 [v], 5 [vi], 19) that were related to standard reporting of AI utilization were reported in all articles. The items with the lowest reporting rates were related to data transparency and included 4a (ii), 5 (iii), and 25, with only 9.1%, 36.4%, and 45.5% of all studies complying, respectively. Conclusions: Orthopaedic RCTs involving AI showed high compliance with respect to standard trial reporting and broad AI descriptors but low compliance with respect to detailed data transparency, data-quality handling, and code accessibility. Addressing these weaker areas is essential to improve reproducibility, reduce bias, and strengthen trust in AI-driven clinical research. Clinical Relevance: Improved compliance with CONSORT-AI reporting standards may help orthopaedic clinicians to critically evaluate AI-based randomized trials, reproduce findings, and determine whether AI interventions are reliable and safe for clinical use.